Devonian Health Group Inc.

TSXV:GSD Stock Report

Market Cap: CA$31.0m

Devonian Health Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Devonian Health Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth31.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Nov 25

A Piece Of The Puzzle Missing From Devonian Health Group Inc.'s (CVE:GSD) 39% Share Price Climb

Devonian Health Group Inc. ( CVE:GSD ) shares have continued their recent momentum with a 39% gain in the last month...
Analysis Article • Sep 11

The Market Lifts Devonian Health Group Inc. (CVE:GSD) Shares 31% But It Can Do More

Devonian Health Group Inc. ( CVE:GSD ) shares have continued their recent momentum with a 31% gain in the last month...
Analysis Article • Jun 12

Take Care Before Jumping Onto Devonian Health Group Inc. (CVE:GSD) Even Though It's 29% Cheaper

Unfortunately for some shareholders, the Devonian Health Group Inc. ( CVE:GSD ) share price has dived 29% in the last...
Analysis Article • Apr 19

Market Cool On Devonian Health Group Inc.'s (CVE:GSD) Revenues Pushing Shares 28% Lower

Devonian Health Group Inc. ( CVE:GSD ) shares have retraced a considerable 28% in the last month, reversing a fair...
Analysis Article • Mar 02

Why Investors Shouldn't Be Surprised By Devonian Health Group Inc.'s (CVE:GSD) 41% Share Price Surge

Devonian Health Group Inc. ( CVE:GSD ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Dec 01

Investors Appear Satisfied With Devonian Health Group Inc.'s (CVE:GSD) Prospects As Shares Rocket 33%

Devonian Health Group Inc. ( CVE:GSD ) shares have had a really impressive month, gaining 33% after a shaky period...
Analysis Article • Mar 20

Is Devonian Health Group (CVE:GSD) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Dec 01

Is Devonian Health Group (CVE:GSD) Using Debt In A Risky Way?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Aug 18

Is Devonian Health Group (CVE:GSD) Weighed On By Its Debt Load?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Apr 24

Does Devonian Health Group (CVE:GSD) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Mar 02

Does Devonian Health Group's (CVE:GSD) CEO Salary Compare Well With Industry Peers?

Andre Boulet became the CEO of Devonian Health Group Inc. ( CVE:GSD ) in 2015, and we think it's a good time to look at...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Devonian Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TSXV:GSD - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
1/31/202610-9-10-10N/A
10/31/202519-7-6-6N/A
7/31/202524-6-1-1N/A
4/30/202532-588N/A
1/31/202531-177N/A
10/31/202424-299N/A
7/31/202419-266N/A
4/30/202410-3-2-2N/A
1/31/20245-4-3-3N/A
10/31/20233-4-4-4N/A
7/31/20232-5-4-4N/A
4/30/20232-5-4-4N/A
1/31/20232-4-4-4N/A
10/31/20222-4-4-4N/A
7/31/20222-3-3-3N/A
4/30/20222-4-2-2N/A
1/31/20222-4-2-2N/A
10/31/20211-3-2-2N/A
7/31/20211-3-2-2N/A
4/30/20211-4-3-3N/A
1/31/20212-4-3-3N/A
10/31/20202-4-2-2N/A
7/31/20202-4-2-2N/A
4/30/20200-4-1-1N/A
1/31/20200-4-2-2N/A
10/31/20193-3N/A-1N/A
7/31/20194-3N/A-1N/A
4/30/20197-3N/A-2N/A
1/31/20198-3N/A-1N/A
10/31/20185-3N/A-3N/A
7/31/20183-3N/A-2N/A
4/30/20182-5N/A-3N/A
1/31/2018N/A-5N/A-3N/A
10/31/2017N/A-5N/A-3N/A
7/31/2017N/A-4N/A-2N/A
4/30/2017N/A-2N/A-2N/A
1/31/2017N/A-2N/A-2N/A
10/31/2016N/A-2N/A-2N/A
7/31/2016N/A-2N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if GSD's forecast earnings growth is above the savings rate (3%).

Earnings vs Market: Insufficient data to determine if GSD's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if GSD's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if GSD's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if GSD's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if GSD's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/24 05:47
End of Day Share Price 2026/05/08 00:00
Earnings2026/01/31
Annual Earnings2025/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Devonian Health Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.